RxDoctor Payments DataLook up a doctor →

Samir Kapadia, MD

Cardiovascular Disease · Cleveland, OHNPI 1356438014

Payments from drug & device makers

$11,065,023in general payments, 2019–2025

Across 778 payments — averaging $14,222 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$5.7M
  • Edwards Lifesciences$4.1M
  • Abbott$1M
  • Siemens Medical Solutions USA, Inc.$167K
  • Biotronik Inc.$30K
  • Livanova USA, Inc.$17K
  • plus $21K from 11 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$11,065,023 in reported general payments places this provider in the 95th percentile of 827 cardiovascular disease providers in Ohio.

See all cardiovascular disease providers in Ohio

Medicare billing

Part B allowed, 2024
$147,755
Medicare patients
241
Services billed
468

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in Cleveland

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →